
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>ORCL 20220531 Analysis</title>
  <link rel="stylesheet" href="styles.css" />
</head>

<body>
  <header>
    <h1>ORCL 20220531 Analysis</h1>
  </header>

  <nav>
    <ul>
      <li><a href="#business">üöÄ Business Development</a></li>
      <li><a href="#risk">‚öñÔ∏è Risk and Opportunities</a></li>
      <li><a href="#financials">üìä Financials</a></li>
      <li><a href="#recommend">üìà Recommendation</a></li>
    </ul>
  </nav>

  <main>
    <!-- url -->
    <section id="business" class="module">
      <h2>üîé Source Data</h2>
      <p>
        <!-- Your text goes here. -->
        <a href="https://www.sec.gov/Archives/edgar/data/1341439/000156459022023675/orcl-10k_20220531.htm">source filing at SEC</a>
      </p>
    </section>
  
    <!-- Business Development (text only) -->
    <section id="business" class="module">
      <h2>üöÄ Business Development</h2>
      <p>
        <!-- Your text goes here. -->
        - Oracle shifted focus to more profitable Oracle Engineered Systems and strategic hardware products while de-emphasizing lower-margin commodity hardware, aiming to optimize profitability amid declining hardware revenues.  <br>- Acquired Cerner Corporation in June 2022, expanding into healthcare IT solutions and positioning Oracle to integrate digital health systems with its cloud infrastructure.  <br>- Increased investment in cloud services and license support, driving growth in cloud revenues despite global supply chain disruptions and pandemic-related challenges.  <br>- Implemented workforce restructuring and hybrid work policies to enhance flexibility, retain talent, and reduce costs, while addressing productivity and cybersecurity risks in remote environments.  <br>- Expanded cloud infrastructure (OCI) offerings, including Oracle Autonomous Database and MySQL HeatWave, leveraging AI/ML to improve performance and automation for enterprise clients.  <br>- Prioritized R&D spending ($7.2B in FY2022) to advance cloud technologies, enhance SaaS applications (e.g., Fusion Cloud ERP, HCM), and integrate emerging tools like IoT and blockchain.  <br>- Strengthened indirect sales channels through partnerships with resellers, system integrators, and ISVs to drive cloud and license adoption, despite risks from channel partner dependencies.  <br>- Addressed supply chain shortages by increasing inventory reserves and securing manufacturing capacity, though higher costs impacted margins and cash flows.  <br>- Grew services business revenue by 6% YoY (constant currency), driven by consulting and customer support in Americas and EMEA regions, offsetting declines in Asia Pacific.  <br>- Launched workforce retention strategies, including equity-based compensation and global hiring in lower-cost regions, amid competitive talent markets and rising compensation pressures.
      </p>
    </section>

    <!-- Risk and Opportunities (text only) -->
    <section id="risk" class="module">
      <h2>‚öñÔ∏è Risk and Opportunities</h2>
      <p>
        <!-- Your text goes here. -->
        Risks:<br>- Cybersecurity threats and data breaches could lead to reputational damage, financial losses, and reduced customer confidence in cloud services.<br>- Intellectual property infringement claims may result in costly litigation, product redesigns, or royalty obligations.<br>- Dependence on third-party components in products increases vulnerability to supply chain security risks.<br>- Evolving global data privacy regulations (e.g., GDPR, healthcare laws) expose the company to compliance costs and penalties.<br>- Difficulty protecting intellectual property rights in jurisdictions with weak enforcement undermines competitive advantages.<br><br>Opportunities:<br>- Growing demand for cloud services drives recurring revenue through subscription models and infrastructure expansion.<br>- Active stock repurchase program ($9.4B remaining) supports shareholder value and capital allocation efficiency.<br>- Strategic acquisitions (e.g., Cerner) expand market reach in healthcare IT and cross-selling opportunities.<br>- High customer renewal rates for license support (71% of total revenue) ensure stable cash flow.<br>- Continued R&D investments ($7.2B annually) fuel innovation in enterprise software and cloud technologies.
      </p>
    </section>

    <!-- Financials (with 4 image cards + 5 horizontal sections of text) -->
    <section id="financials" class="module">
      <h2>üìä Financials</h2>

      <!-- Four cards with images (responsive layout) -->
      <div class="card-container">
        <div class="card">
          <img src="ORCL_20220531_1.jpg" alt="Financial Chart 1" />
        </div>
        <div class="card">
          <img src="ORCL_20220531_2.jpg" alt="Financial Chart 2" />
        </div>
        <div class="card">
          <img src="ORCL_20220531_3.jpg" alt="Financial Chart 3" />
        </div>
        <div class="card">
          <img src="ORCL_20220531_4.jpg" alt="Financial Chart 4" />
        </div>
      </div>

      <!-- 5 horizontal sections (each a text paragraph) -->
      <section class="horizontal-section" id="key-items">
        <h3>Key Items</h3>
        <p>
          <!-- Your text goes here. -->
          - Acquisition-related and operating expenses rose significantly as a percentage of revenue, driving a 28.1% operating income decline and 51.1% net income drop year-over-year.  <br>- Operating income and net income as a percentage of revenue decreased sharply, with non-operating expenses becoming material and income tax provision shifting from positive to negative.  <br>- Cash and equivalents fell from 22.9% to 19.5% of total assets, while marketable securities plummeted from 12.5% to 0.5%, indicating reduced liquidity.  <br>- Property, plant, and equipment increased from 5.4% to 8.9% of assets, signaling capital investment, while intangible assets declined from 1.9% to 1.3%.  <br>- Current notes payable decreased from 6.3% to 3.4% of liabilities, though accounts payable doubled from 0.6% to 1.2%.  <br>- Shareholders' equity deteriorated sharply from 4.0% to -5.7% of total liabilities/equity, with total equity declining 96.7% year-over-year.  <br>- Total assets decreased by 16.8%, reflecting portfolio rebalancing and reduced marketable securities holdings.
        </p>
      </section>

      <section class="horizontal-section" id="profitability-analysis">
        <h3>Profitability Analysis</h3>
        <p>
          <!-- Your text goes here. -->
          - Net profit margin declined from 33.9% (2021) to 15.8% (2022) due to 51% net income drop ($13,746M to $6,717M) and 24.7% operating expense increase.  <br>- Operating profit margin fell from 37.6% to 25.7%, driven by higher R&D, sales costs, and stock-based compensation.  <br>- ROA decreased from 10.5% to 6.1%, reflecting reduced asset efficiency despite a 16.6% smaller asset base ($109,297M in 2022).  <br>- ROE turned negative (-116.5% in 2022 vs. 231% in 2021) due to negative equity from $28.2B Cerner acquisition increasing liabilities.  <br>- Total equity shifted to negative, indicating financial strain from acquisition-related debt and integration costs.  <br>- Revenue recognition timing (particularly cloud services) and foreign exchange fluctuations further pressured profitability.  <br>- Operational inefficiencies and currency impacts contributed to lower net income, highlighting strategic adjustment needs.
        </p>
      </section>

      <section class="horizontal-section" id="liquidity-analysis">
        <h3>Liquidity Analysis</h3>
        <p>
          <!-- Your text goes here. -->
          - Current Ratio declined to 1.62x in 2022 ($31.6B current assets / $19.5B liabilities) from 2.30x in 2021 ($55.6B / $24.2B), driven by $3.8B long-term debt reclassified as current liabilities and $16.2B stock repurchases.  <br>- Cash Ratio fell to 1.10x in 2022 ($21.4B cash / $19.5B liabilities) from 1.24x in 2021 ($30.1B / $24.2B) due to $16.2B stock buybacks and $4.7B litigation charges reducing cash reserves.  <br>- Quick Ratio remained incalculable both years due to missing inventory data disclosure.  <br>- Operating cash flow dropped 40% YoY, limiting liquidity buffer for obligations.  <br>- Current liabilities rose 23% in 2022, partially from $3.8B debt reclassification reducing long-term debt.  <br>- Liquidity erosion reflects cash-intensive activities (acquisitions, buybacks) outweighing operational cash generation.
        </p>
      </section>

      <section class="horizontal-section" id="solvency-analysis">
        <h3>Solvency Analysis</h3>
        <p>
          <!-- Your text goes here. -->
          - Debt-to-Equity ratio turned negative in 2022 due to liabilities exceeding assets (-$5,768 equity), worsened by $16.2 billion stock repurchases and increased borrowings (2021 ratio: 21.05).  <br>- Interest Coverage ratio declined from 6.10 (2021) to 3.96 (2022) due to higher interest expenses from $15 billion senior notes issued in 2021 and lower EBIT ($10,926 vs. $15,213).  <br>- Equity Ratio dropped from 4.5% (2021) to negative (2022) primarily from stock buybacks, $1.692 billion unrealized losses on securities, and impairment charges eroding equity.  <br>- Total debt increased with $15 billion senior notes issued in March 2021, partially offset by $8.3 billion repayments in 2022.  <br>- Cash and marketable securities fell 53% to $21.9 billion in 2022, reducing liquidity for obligations and growth investments.  <br>- Negative equity position reflects high financial leverage, with total liabilities at $115,065 (2022) versus $109,297 total assets.  <br>- Declining EBIT combined with rising interest expenses ($2,755 in 2022 vs. $2,496 in 2021) reduced debt service capacity.  <br>- Share repurchases totaling $16.2 billion in 2022 directly reduced equity, exacerbating solvency risks.  <br>- Comprehensive losses and investment impairments further weakened the equity base, signaling long-term financial stability concerns.
        </p>
      </section>

      <section class="horizontal-section" id="efficiency-analysis">
        <h3>Efficiency Analysis</h3>
        <p>
          <!-- Your text goes here. -->
          - Days Sales Outstanding (DSO) increased from 49 days (2021) to 51 days (2022), indicating slower accounts receivable collections.  <br>- Hardware revenue declines and customer financial struggles likely delayed payments, contributing to higher DSO.  <br>- Workforce restructuring disrupted operational efficiency in accounts receivable management processes.  <br>- Reliance on indirect sales channels (resellers, integrators) extended payment cycles due to intermediary payment terms.  <br>- COVID-19 supply chain disruptions may have indirectly caused customer payment delays.  <br>- Inventory and COGS data absence prevented Days Inventory Outstanding (DIO) and Days Payable Outstanding (DPO) calculations.  <br>- Cash Conversion Cycle (CCC) analysis remained incomplete for 2021 and 2022 due to missing DIO/DPO metrics.  <br>- Accounts receivable management improvements are critical to address collection inefficiencies highlighted by rising DSO.
        </p>
      </section>
    </section>

    <!-- Recommendation (text only) -->
    <section id="recommend" class="module">
      <h2>üìà Recommendation: ‚ùå SELL</h2>
      <p>
        <!-- Your text goes here. -->
        Oracle's financial statements indicate declining net income, increasing operating expenses, negative equity, and weakened liquidity and solvency positions. These factors, combined with rising expenses outpacing revenue growth, suggest that earnings per share (EPS) will likely decrease next year unless significant strategic changes are implemented.
      </p>
    </section>
  </main>

  <footer>
    <p>¬© 2025 SnapStock Report</p>
  </footer>
</body>
</html>


